Moderate-to-Severe Hidradenitis Suppurativa Study
Disease/Condition: Hidradenitis Suppurativa
Enrollment Opens: 03-02-2022
Enrollment Closes: TBD
This clinical trial is evaluating the efficacy and safety of an investigational medication in subjects with moderate-to-severe hidradenitis suppurativa. Participants must have at least three active lesions in two different body areas.
Study ID: OMRC-000145
To Enroll: Visit http://www.oregonmedicalresearch.com to learn more and fill out the contact form, or call 503-245-1525 to contact us directly.
Posted by: Oregon Medical Research Center | http://www.oregonmedicalresearch.com